Even though obese patients and patients who had T2D combined with cardiovascular disease showed increased levels of plasma CTSS, NALFD patients did not have different levels of plasma CTSS compared to healthy controls [60]. This evidence concerns the gene CTSS and type 2 diabetes mellitus.